Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ETS transcription factor ELK2A, pseudogene (ELK2AP)
- Target
- ELK2AP
- Molecular classification
- Pseudogene, Transcription factor—ETS family (Parental/related family)
01
Overview
ETS transcription factor ELK2A, pseudogene (ELK2AP) is a genomic sequence related to the ETS family of transcription factors, but is classified as a pseudogene, meaning it is not believed to produce a functional protein product[6]. The ETS family itself is well known for its highly conserved DNA-binding ETS domain involved in gene regulation relating to cellular differentiation, proliferation, apoptosis, and cancer. However, pseudogenes like ELK2AP do not contribute to these functions and are not recognized as receptors, enzymes, or clinically actionable targets[1][6]. There is no credible evidence supporting a therapeutic or physiological function specific to ELK2AP. ELK2AP is a non-functional pseudogene and should not be confused with functional ETS transcription factor family members. It is not considered a therapeutic or biological target. The presence of aliases and parental family (e.g., ETS transcription factors) may cause confusion, but ELK2AP specifically refers to the pseudogene[6][2].
- Other names
- ELK2ELK2.1ELK2P1
Beyond the preview
Go deeper on ETS transcription factor ELK2A, pseudogene (ELK2AP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ETS transcription factor ELK2A, pseudogene (ELK2AP).